Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
PRODUCT INTRODUCTION
Ramiven 150mg Tablet is an anti-cancer medication prescribed for the treatment of metastatic breast cancer. Its primary function is to decelerate the growth of cancer cells and eventually induce their demise. By doing so, it addresses symptoms associated with breast cancer, such as the presence of breast lumps, bloody discharge from nipples, or alterations in breast shape.
Ramiven 150mg Tablet can be taken with or without food and is typically administered alongside another medication. The duration of treatment varies depending on individual needs and response to the medication. It is imperative to adhere strictly to the prescribed dosage and duration. Your doctor may request regular blood tests while you are on this medication.
USES OF RAMIVEN TABLET
Metastatic breast cancer
BENEFITS OF RAMIVEN TABLET
In the context of metastatic breast cancer:
Ramiven 150mg Tablet effectively manages breast cancer and can be employed either as a standalone treatment or in combination with other medications or treatment modalities, such as chemotherapy. This medication is utilized when other treatments have failed to yield significant improvement and the cancer has metastasized. It alleviates symptoms associated with breast cancer, including breast lumps, bloody discharge from nipples, or changes in breast shape or texture. Ramiven 150mg Tablet achieves its therapeutic effect by either eliminating cancer cells or halting their proliferation. If you experience any side effects, it is advisable to discuss them with your doctor.
MECHANISM OF ACTION OF RAMIVEN TABLET
Ramiven 150mg Tablet functions by obstructing the activity of an abnormal protein responsible for stimulating the proliferation of cancer cells. This mechanism helps to impede or prevent the spread of cancer cells within the body.